Literature DB >> 22615432

Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice.

Ruo-Li Chen1, Simon Nagel, Michalis Papadakis, Tammie Bishop, Patrick Pollard, Peter J Ratcliffe, Christopher W Pugh, Alastair M Buchan.   

Abstract

This study investigated the function of each of the hypoxia inducible factor (HIF) prolyl-4-hydroxylase enzymes (PHD1–3) in the first 24 h following transient focal cerebral ischaemia by using mice with each isoform genetically suppressed. Male, 8- to 12-week old PHD1−/−, PHD2+/− and PHD3−/− mice and their wild-type (WT) littermate were subjected to 45 min of middle cerebral artery occlusion (MCAO). During the experiments, regional cerebral blood flow (rCBF) was recorded by laser Doppler flowmetry. Behaviour was assessed at both 2 h and 24 h after reperfusion with a common neuroscore. Infarct volumes, blood–brain barrier (BBB) disruption, cerebral vascular density, apoptosis, reactive oxygen species (ROS), HIF1α, and glycogen levels were then determined using histological and immunohistochemical techniques. When compared to their WT littermates, PHD2+/− mice had significantly increased cerebral microvascular density and more effective restoration of CBF upon reperfusion. PHD2+/− mice showed significantly better functional outcomes and higher activity rates at both 2 h and 24 h after MCAO, associated with significant fewer apoptotic cells in the penumbra and less BBB disruption; PHD3−/− mice had impaired rCBF upon early reperfusion but comparable functional outcomes; PHD1−/− mice did not show any significant changes following the MCAO. Production of ROS, HIF1α staining and glycogen content in the brain were not different in any comparison. Life-long genetic inhibition of PHD enzymes produces different effects on outcome in the first 24 h after transient cerebral ischaemia. These need to be considered in optimizing therapeutic effects of PHD inhibitors, particularly when isoform specific inhibitors become available.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22615432      PMCID: PMC3476649          DOI: 10.1113/jphysiol.2012.232884

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  49 in total

1.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

2.  Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.

Authors:  Stephen A Bernard; Timothy W Gray; Michael D Buist; Bruce M Jones; William Silvester; Geoff Gutteridge; Karen Smith
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

3.  Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing.

Authors:  Eric Metzen; Utta Berchner-Pfannschmidt; Petra Stengel; Jan H Marxsen; Ineke Stolze; Matthias Klinger; Wei Qi Huang; Christoph Wotzlaw; Thomas Hellwig-Bürgel; Wolfgang Jelkmann; Helmut Acker; Joachim Fandrey
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

4.  Cerebral blood flow alteration in neuroprotection following cerebral ischaemia.

Authors:  Brad A Sutherland; Michalis Papadakis; Ruo-Li Chen; Alastair M Buchan
Journal:  J Physiol       Date:  2011-06-27       Impact factor: 5.182

5.  Short hairpin RNA interference therapy for ischemic heart disease.

Authors:  Mei Huang; Denise A Chan; Fangjun Jia; Xiaoyan Xie; Zongjin Li; Grant Hoyt; Robert C Robbins; Xiaoyuan Chen; Amato J Giaccia; Joseph C Wu
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

Review 6.  Therapeutic manipulation of the HIF hydroxylases.

Authors:  Simon Nagel; Nick P Talbot; Jasmin Mecinović; Thomas G Smith; Alastair M Buchan; Christopher J Schofield
Journal:  Antioxid Redox Signal       Date:  2010-04       Impact factor: 8.401

Review 7.  Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke.

Authors:  Junying Yuan
Journal:  Apoptosis       Date:  2009-04       Impact factor: 4.677

8.  Neuroprotection in diet-induced ketotic rat brain after focal ischemia.

Authors:  Michelle A Puchowicz; Jennifer L Zechel; Jose Valerio; Douglas S Emancipator; Kui Xu; Svetlana Pundik; Joseph C LaManna; W David Lust
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-23       Impact factor: 6.200

9.  A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia.

Authors:  Masaomi Nangaku; Yuko Izuhara; Shunya Takizawa; Toshiharu Yamashita; Yoshiaki Fujii-Kuriyama; Osamu Ohneda; Masayuki Yamamoto; Charles van Ypersele de Strihou; Noriaki Hirayama; Toshio Miyata
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-11       Impact factor: 8.311

10.  Identification of hypoxia-induced genes in human SGBS adipocytes by microarray analysis.

Authors:  Kathrin Geiger; Andreas Leiherer; Axel Muendlein; Nicole Stark; Simone Geller-Rhomberg; Christoph H Saely; Martin Wabitsch; Peter Fraunberger; Heinz Drexel
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

View more
  14 in total

1.  The PHD1 oxygen sensor in health and disease.

Authors:  Kilian B Kennel; Julius Burmeister; Martin Schneider; Cormac T Taylor
Journal:  J Physiol       Date:  2018-03-05       Impact factor: 5.182

2.  HIF1α stabilization in hypoxia is not oxidant-initiated.

Authors:  Amit Kumar; Manisha Vaish; Saravanan S Karuppagounder; Irina Gazaryan; John W Cave; Anatoly A Starkov; Elizabeth T Anderson; Sheng Zhang; John T Pinto; Austin M Rountree; Wang Wang; Ian R Sweet; Rajiv R Ratan
Journal:  Elife       Date:  2021-10-01       Impact factor: 8.140

3.  Iptakalim improves cerebral microcirculation in mice after ischemic stroke by inhibiting pericyte contraction.

Authors:  Ruo-Bing Guo; Yin-Feng Dong; Zhi Yin; Zhen-Yu Cai; Jin Yang; Juan Ji; Yu-Qin Sun; Xin-Xin Huang; Teng-Fei Xue; Hong Cheng; Xi-Qiao Zhou; Xiu-Lan Sun
Journal:  Acta Pharmacol Sin       Date:  2021-10-25       Impact factor: 7.169

4.  Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism.

Authors:  Annelies Quaegebeur; Inmaculada Segura; Roberta Schmieder; Dries Verdegem; Ilaria Decimo; Francesco Bifari; Tom Dresselaers; Guy Eelen; Debapriva Ghosh; Shawn M Davidson; Sandra Schoors; Dorien Broekaert; Bert Cruys; Kristof Govaerts; Carla De Legher; Ann Bouché; Luc Schoonjans; Matt S Ramer; Gene Hung; Goele Bossaert; Don W Cleveland; Uwe Himmelreich; Thomas Voets; Robin Lemmens; C Frank Bennett; Wim Robberecht; Katrien De Bock; Mieke Dewerchin; Bart Ghesquière; Sarah-Maria Fendt; Peter Carmeliet
Journal:  Cell Metab       Date:  2016-01-07       Impact factor: 27.287

5.  Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke.

Authors:  Stefan Reischl; Lexiao Li; Gail Walkinshaw; Lee A Flippin; Hugo H Marti; Reiner Kunze
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

Review 6.  Signaling hypoxia by hypoxia-inducible factor protein hydroxylases: a historical overview and future perspectives.

Authors:  Tammie Bishop; Peter J Ratcliffe
Journal:  Hypoxia (Auckl)       Date:  2014-12-05

7.  Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models.

Authors:  Saravanan S Karuppagounder; Ishraq Alim; Soah J Khim; Megan W Bourassa; Sama F Sleiman; Roseleen John; Cyrille C Thinnes; Tzu-Lan Yeh; Marina Demetriades; Sandra Neitemeier; Dana Cruz; Irina Gazaryan; David W Killilea; Lewis Morgenstern; Guohua Xi; Richard F Keep; Timothy Schallert; Ryan V Tappero; Jian Zhong; Sunghee Cho; Frederick R Maxfield; Theodore R Holman; Carsten Culmsee; Guo-Hua Fong; Yijing Su; Guo-li Ming; Hongjun Song; John W Cave; Christopher J Schofield; Frederick Colbourne; Giovanni Coppola; Rajiv R Ratan
Journal:  Sci Transl Med       Date:  2016-03-02       Impact factor: 17.956

Review 8.  Neuroprotection for stroke: current status and future perspectives.

Authors:  Jens Minnerup; Brad A Sutherland; Alastair M Buchan; Christoph Kleinschnitz
Journal:  Int J Mol Sci       Date:  2012-09-18       Impact factor: 6.208

9.  Inhibition of HIF-prolyl-4-hydroxylases prevents mitochondrial impairment and cell death in a model of neuronal oxytosis.

Authors:  S Neitemeier; A M Dolga; B Honrath; S S Karuppagounder; I Alim; R R Ratan; C Culmsee
Journal:  Cell Death Dis       Date:  2016-05-05       Impact factor: 8.469

10.  Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases.

Authors:  Rasheduzzaman Chowdhury; Ivanhoe K H Leung; Ya-Min Tian; Martine I Abboud; Wei Ge; Carmen Domene; François-Xavier Cantrelle; Isabelle Landrieu; Adam P Hardy; Christopher W Pugh; Peter J Ratcliffe; Timothy D W Claridge; Christopher J Schofield
Journal:  Nat Commun       Date:  2016-08-26       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.